We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBNK
6426
DELISTED
First Connecticut Bancorp, Inc
FBNK
$2K ﹤0.01%
+64
New +$1.49K
JNP
6427
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2K ﹤0.01%
+497
New +$2.51K
EEB
6428
DELISTED
Invesco BRIC ETF
EEB
$2K ﹤0.01%
79
RICE
6429
CALL
DELISTED
Rice Energy Inc.
RICE
$2K ﹤0.01%
+100
New +$2.08K
GUID
6430
DELISTED
Guidance Software, Inc.
GUID
$2K ﹤0.01%
217
-56
-21% -$382
BSPM
6431
DELISTED
Biostar Pharmaceuticals, Inc.
BSPM
$2K ﹤0.01%
1,000
+530
+113% +$1.39K
CTIC
6432
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2K ﹤0.01%
522
-30
-5% -$138
KNL
6433
CALL
DELISTED
Knoll, Inc.
KNL
$2K ﹤0.01%
+100
New +$2.47K
KNL
6434
PUT
DELISTED
Knoll, Inc.
KNL
$2K ﹤0.01%
100
AMNB
6435
DELISTED
American National Bankshares Inc
AMNB
$2K ﹤0.01%
43
-35
-45% -$1.26K
VEDL
6436
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$2K ﹤0.01%
134
+59
+79% +$893
PGLC
6437
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
$2K ﹤0.01%
+660
New +$2.07K
CSBK
6438
DELISTED
Clifton Bancorp Inc.
CSBK
$2K ﹤0.01%
115
-295
-72% -$4.75K
KMI.WS
6439
DELISTED
Kinder Morgan Inc
KMI.WS
$2K ﹤0.01%
1,050,981
ETRM
6440
DELISTED
EnteroMedics Inc.
ETRM
$2K ﹤0.01%
+401
New +$2.96K
TCF
6441
CALL
DELISTED
TCF Financial Corporation
TCF
$2K ﹤0.01%
+100
New +$1.78K
ACNB icon
6442
ACNB Corp
ACNB
$646M
$1K ﹤0.01%
+27
New +$806
AMRC icon
6443
Ameresco
AMRC
$980M
$1K ﹤0.01%
+268
New +$1.47K
APPF icon
6444
AppFolio
APPF
$6.62B
$1K ﹤0.01%
+35
New +$836
APT icon
6445
Alpha Pro Tech
APT
$49.9M
$1K ﹤0.01%
+296
New +$897
ASHR icon
6446
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
$1K ﹤0.01%
25
-41
-62% -$1.02K
ATLO icon
6447
AMES National
ATLO
$271M
$1K ﹤0.01%
44
-69
-61% -$2.2K
BBW icon
6448
Build-A-Bear
BBW
$445M
$1K ﹤0.01%
62
-23,838
-100% -$254K
BOOM icon
6449
DMC Global
BOOM
$111M
$1K ﹤0.01%
+79
New +$1.19K
BTG icon
6450
B2Gold
BTG
$4.98B
$1K ﹤0.01%
411

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.